Page last updated: 2024-08-24

2-oxindole and Ductal Carcinoma

2-oxindole has been researched along with Ductal Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ali, S; Azmi, AS; Banerjee, S; Bao, B; Beck, FW; Choi, M; Maitah, M; Mohammad, RM; Philip, PA; Sarkar, FH; Shields, TF; Wang, Z1

Other Studies

1 other study(ies) available for 2-oxindole and Ductal Carcinoma

ArticleYear
Network modeling of MDM2 inhibitor-oxaliplatin combination reveals biological synergy in wt-p53 solid tumors.
    Oncotarget, 2011, Volume: 2, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Ductal; Cell Line, Tumor; Computational Biology; Computer Simulation; Cyclic AMP Response Element-Binding Protein; DNA-Binding Proteins; Drug Synergism; Early Growth Response Protein 1; Gene Expression Profiling; Gene Expression Regulation; Gene Regulatory Networks; Humans; Indoles; Microarray Analysis; Molecular Targeted Therapy; Organoplatinum Compounds; Oxaliplatin; Oxindoles; Pancreatic Neoplasms; Platinum Compounds; Proto-Oncogene Proteins c-mdm2; RNA, Small Interfering; Spiro Compounds; Transcription Factors; Tumor Suppressor Protein p53

2011